JP2008526935A5 - - Google Patents

Download PDF

Info

Publication number
JP2008526935A5
JP2008526935A5 JP2007550830A JP2007550830A JP2008526935A5 JP 2008526935 A5 JP2008526935 A5 JP 2008526935A5 JP 2007550830 A JP2007550830 A JP 2007550830A JP 2007550830 A JP2007550830 A JP 2007550830A JP 2008526935 A5 JP2008526935 A5 JP 2008526935A5
Authority
JP
Japan
Prior art keywords
use according
drug
intended
wound
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007550830A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008526935A (ja
Filing date
Publication date
Priority claimed from GBGB0500643.2A external-priority patent/GB0500643D0/en
Application filed filed Critical
Publication of JP2008526935A publication Critical patent/JP2008526935A/ja
Publication of JP2008526935A5 publication Critical patent/JP2008526935A5/ja
Pending legal-status Critical Current

Links

JP2007550830A 2005-01-13 2006-01-06 創傷治癒のためのil−10関連ペプチド Pending JP2008526935A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0500643.2A GB0500643D0 (en) 2005-01-13 2005-01-13 Medicaments
PCT/GB2006/000051 WO2006075138A2 (en) 2005-01-13 2006-01-06 Il-10 related peptides for wound healing

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012165481A Division JP2012211185A (ja) 2005-01-13 2012-07-26 創傷治癒のためのil−10関連ペプチド

Publications (2)

Publication Number Publication Date
JP2008526935A JP2008526935A (ja) 2008-07-24
JP2008526935A5 true JP2008526935A5 (https=) 2009-02-26

Family

ID=34224534

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007550830A Pending JP2008526935A (ja) 2005-01-13 2006-01-06 創傷治癒のためのil−10関連ペプチド
JP2012165481A Pending JP2012211185A (ja) 2005-01-13 2012-07-26 創傷治癒のためのil−10関連ペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012165481A Pending JP2012211185A (ja) 2005-01-13 2012-07-26 創傷治癒のためのil−10関連ペプチド

Country Status (7)

Country Link
US (3) US20080139478A1 (https=)
EP (2) EP2332566A1 (https=)
JP (2) JP2008526935A (https=)
AU (1) AU2006205696C1 (https=)
CA (1) CA2594798A1 (https=)
GB (1) GB0500643D0 (https=)
WO (1) WO2006075138A2 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0500643D0 (en) 2005-01-13 2005-02-23 Renovo Ltd Medicaments
AU2007319811A1 (en) * 2006-11-15 2008-05-22 Coda Therapeutics, Inc. Improved methods and compositions for wound healing
CA2767132C (en) 2009-07-06 2017-06-20 Astrazeneca Ab Intermediates and processes for the preparation of 4-(acetylamino))-3-[(4-chloro-phenyl)thio]-2-methyl-1h-indole-1-acetic acid
WO2012135842A2 (en) * 2011-03-31 2012-10-04 President And Fellows Of Harvard College A unique population of regulatory t cells that regulate tissue regeneration and wound healing
BR112015022747B1 (pt) * 2013-03-14 2020-10-13 3-D Matrix, Ltd kit para prevenção de estenose e uso de um peptídeo de automontagem
EP2986306A4 (en) 2013-04-18 2016-12-07 Armo Biosciences Inc METHOD FOR USE OF INTERLEUKIN-10 FOR THE TREATMENT OF ILLNESSES AND SUFFERING
ES2688206T3 (es) 2013-06-17 2018-10-31 Armo Biosciences, Inc. Procedimiento de evaluación de la identidad y la estabilidad de proteínas
US10098929B2 (en) 2013-08-02 2018-10-16 Children's Hospital Medical Center Method of reducing scar formation in healing of dermal wounds by administering interleukin-10 and hyaluronan
CN105658232A (zh) 2013-08-30 2016-06-08 阿尔莫生物科技股份有限公司 使用白细胞介素-10治疗疾病和病症的方法
EP3068425B1 (en) 2013-11-11 2021-01-27 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
WO2015187295A2 (en) 2014-06-02 2015-12-10 Armo Biosciences, Inc. Methods of lowering serum cholesterol
WO2016060996A2 (en) 2014-10-14 2016-04-21 Armo Biosciences, Inc. Interleukin-15 compositions and uses thereof
AU2015336101A1 (en) 2014-10-22 2017-04-20 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US10618970B2 (en) 2015-02-03 2020-04-14 Armo Biosciences, Inc. Method of treating cancer with IL-10 and antibodies that induce ADCC
CA2986755A1 (en) 2015-05-28 2016-12-01 Armo Biosciences, Inc. Pegylated interleukin-10 for use in treating cancer
US10398761B2 (en) 2015-08-25 2019-09-03 Armo Biosciences, Inc. Methods of using combinations of PEG-IL-10 and IL-15 for treating cancers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6217857B1 (en) * 1989-06-28 2001-04-17 Schering Corporation Cytokine synthesis inhibitory factor (IL-10) and pharmaceutical compositions thereof
US6159937A (en) * 1994-07-05 2000-12-12 Steeno Research Group A/S Immunomodulators
GB2304047A (en) * 1995-08-09 1997-03-12 Univ Manchester Pharmaceutical compositions containing cytokines
AU4385696A (en) * 1996-01-18 1997-08-11 Christian Gronhoj Larsen Synthetic il-10 analogues
GB0500643D0 (en) 2005-01-13 2005-02-23 Renovo Ltd Medicaments

Similar Documents

Publication Publication Date Title
JP2008526935A5 (https=)
AU2002334886B2 (en) Methods and compositions for treating dermal lesions
RU2008136324A (ru) Желудочно-кишечный пролиферативный фактор и его применения
JP2012506442A5 (https=)
US20110160118A1 (en) Methods and compositions for treating oral and esophageal lesions
JP2005516885A5 (https=)
HRP20140616T1 (hr) Peptidni analog oksintomodulina
JP2012500847A5 (https=)
US7538082B2 (en) Methods and compositions for treating oral and esophageal lesions
SA110310710B1 (ar) عوامل مساعدة لمستقبل أوكسيتوسين
WO1999006440A8 (en) Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome
TWI305778B (en) Peptides of an expressing unit for igf-i minimal activity and their pharmaceutical use
NO20062198L (no) Bradykinin B1 reseptorantagonister
CA2825247A1 (en) Human lactoferrin derived peptides and their use
PT1427436E (pt) Utilização de apoproteínas do soro do leite na profilaxia ou tratamento de infecção microbiana ou viral
JP2009535330A5 (https=)
CA2952475A1 (en) Vip fragment for the treatment of myocardial fibrosis
JP2004538320A5 (https=)
CN101679495A (zh) 用于细胞学和免疫学调节的短的生物活性肽
CA2423004A1 (en) Peptide inhibitors of hiv entry
EP2205270A1 (en) Peptides based on the sequence of human lactoferrin and their use
US20120295851A1 (en) Peptides, compositions and uses thereof
US8853359B2 (en) Endokinin C/D-derived peptides
CN114349870B (zh) 一种兼具防粘连功效的重组抗菌肽及其制备方法和应用
CN101602796A (zh) 一种含硒活性多肽及其制备方法与应用